Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Agents and Actions|September 1, 1991
Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitorsL A Tomchek, D A Hartman, A C Lewin, et al.
Critical Care Nurse|February 3, 2016
A Bedside Decision Tree for Use of Saline With Endotracheal Tube Suctioning in ChildrenErin B Owen, Charles R Woods, Justine A O'Flynn, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|November 9, 2017
The Development and Validation of a Concise Instrument for Formative Assessment of Team Leader Performance During Simulated Pediatric ResuscitationsLindsay D Nadkarni, Cindy G Roskind, Marc A Auerbach, et al.
Environmental Toxicology and Pharmacology|July 14, 2017
Assessing human metal accumulations in an urban superfund siteM Katie Hailer, Christopher P Peck, Michael W Calhoun, et al.
Agents and Actions|June 1, 1989
Pharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouseW Calhoun, J Yu, A Sung, et al.
Biochemistry|November 2, 1993
Site-directed mutants of the cytochrome bo ubiquinol oxidase of Escherichia coli: amino acid substitutions for two histidines that are putative CuB ligandsM W Calhoun, J J Hill, L J Lemieux, et al.
FEBS Letters|July 24, 1995
The highly conserved methionine of subunit I of the heme-copper oxidases is not at the heme-copper dinuclear center: mutagenesis of M110 in subunit I of cytochrome bo3-type ubiquinol oxidase from Escherichia coliM W Calhoun, L J Lemieux, J A Garcia-Horsman, et al.
Medical Care|June 4, 2008
Addressing the unit of analysis in medical care studies: a systematic reviewAaron W Calhoun, Gordon H Guyatt, Michael D Cabana, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|August 11, 2020
Guidelines for the Responsible Use of Deception in Simulation: Ethical and Educational ConsiderationsAaron W Calhoun, May Pian-Smith, Anjan Shah, et al.
Agents and Actions|March 1, 1989
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammationR P Carlson, L O'Neill-Davis, W Calhoun, et al.
Pageof 9